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Dear Editor,
The recent article on bonemineral density in postmenopausal
women with and without breast cancer was very interest-
ing. Conde et al. concluded that The prevalence of abnormal
bone mineral density (BMD) was higher in postmenopausal
breast cancer survivors (BCS) than in postmenopausal women
without breast cancer”.1 Certainly, the concern regarding
osteoporosis in the cancerous patient is very important. As
Conde et al. mentioned, “special vigilance and the adoption
of interventions should be instituted early to minimize bone
loss”. Indeed, cancer therapy should also be focused on mon-
itoring osteoporosis among cancerous patients. The use of
aromatase inhibitor as an adjuvant therapy in breast can-
cer is quite intriguing.2 It was recently reported that the use
of aromatase inhibitor signiﬁcantly increased osteoporosis,
especially at femur region.2
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